Human Biglycan PharmaGenie ELISA Kit (SBRS0303)

Quantitative measurement of human biglycan drives the Assay Genie Human Biglycan PharmaGenie ELISA Kit, which targets a small leucine-rich extracellular matrix proteoglycan involved in collagen fibril organization, connective tissue maintenance, and remodeling processes studied across musculoskeletal, renal, dermatological, and cardiovascular research programs. The assay reacts with biglycan captured from cell culture supernatant or human biofluid specimens (such as plasma-derived and serum-derived fractions), producing a colorimetric signal that can be quantified on a standard microplate reader. Investigators working on age-related changes in dermal architecture, kidney injury biomarkers, or tumor-microenvironment biology can apply the kit to in vitro workflows and translational sample cohorts. Each kit supplies a pre-coated microplate, detection antibody, reference standards, and buffers in a 96-assay pack size, supporting either full-plate processing in one session or partial-plate use for smaller batches. Components should be stored refrigerated upon arrival to preserve antibody activity and the kit's shelf-life stability. The protocol included with the kit outlines reagent preparation, sample dilution guidance, and curve-fitting steps for reproducible performance in cell-based and biofluid biomarker studies.